(Q24298552)

positive regulation of transforming growth factor beta production

GOA release 2020-03-11

1 reference

Serine (or cysteine) peptidase inhibitor, clade F, member 2

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

author name string

Y Kanno

1

0 references

A Kuroki

2

0 references

K Okada

3

0 references

K Tomogane

4

0 references

S Ueshima

5

0 references

O Matsuo

6

0 references

H Matsuno

Journal of Thrombosis and Haemostasis

7

0 references

language of work or name

English

0 references

publication date

November 2007

0 references

published in

0 references

volume

5

0 references

issue

11

0 references

page(s)

2266-73

0 references

cites work

Transforming growth factor beta in tissue fibrosis

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2007.02745.X

Identification and Some Properties of a New Fast-Reacting Plasmin Inhibitor in Human Plasma

20 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02745.X

Smad3 as a mediator of the fibrotic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02745.X

Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02745.X

Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02745.X

Vascular endothelial cell growth factor attenuates actions of transforming growth factor-beta in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02745.X

Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02745.X

Fibrin-induced skin fibrosis in mice deficient in tissue plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02745.X

Gene manipulation and transfer of the plasminogen and coagulation system in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02745.X

7 January 2021

Plasma plasmin-alpha2-plasmin inhibitor complex levels are increased in systemic sclerosis patients with pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02745.X

7 January 2021

Topical application of a peptide inhibitor of transforming growth factor-beta1 ameliorates bleomycin-induced skin fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02745.X

7 January 2021

Characterization of the interaction between plasminogen and staphylokinase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02745.X

7 January 2021

Lack of alpha2-antiplasmin improves cutaneous wound healing via over-released vascular endothelial growth factor-induced angiogenesis in wound lesions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02745.X

7 January 2021

Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02745.X

7 January 2021

PAI-1, fibrosis, and the elusive provisional fibrin matrix

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02745.X

7 January 2021

Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02745.X

7 January 2021

Lack of alpha 2-antiplasmin promotes re-endothelialization via over-release of VEGF after vascular injury in mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02745.X

7 January 2021